We are 4-Amino-3-hydroxybenzoic acid CAS:4-氨基-3-羟基苯甲酸 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Yellowish to gray powder | Conform |
| Assay | ≥98.0% | 99.10% |
| Single impurity | ≤0.5% | 0.31% |
| Solvent residue | ≤0.2% | 0.02% |
| Melting point | 211-215℃ | 211-213℃ |
| Loss on drying | ≤0.5% | 0.37% |
| Conclusion | Conforms to Factory Standard | |
Related News: 5-(Trifluoromethyl)indole CAS:100846-24-0 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.592-09-6 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.38234-21-8 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.
| Product Name | |
|---|---|
| D-PLENYLGLYCINOL Cas:56613-80-0 | View Details |
| CAS:2943-75-1 Chisso S301 | View Details |
| Bisacodyl Cas:603-50-9 | View Details |